INTRODUCTION
Gram-negative infections with the release of endotoxin induces a catabolic state with increased muscle protein breakdown and decreased protein synthesis and if sustained this leads to considerable loss of lean body mass which has an adverse effect on morbidity and mortality (5, 11) . Endotoxins are lipopolysaccharides (LPS) derived from the outer bacterial membrane, and its entry into the circulation activates many of the clinical manifestations of sepsis (8) . In humans and animals LPS induces an inflammatory response with the release of glucocorticoids, catecholamies and pro-inflammatory cytokines such as TNF and IL-6 that in turn activate the catabolic process (6) . This is partly a consequence of a fall in circulating levels or tissue responsiveness, to anabolic hormones such as growth hormone, IGF-1, insulin and testosterone (6, 34) . Administration of LPS causes an early increase in circulating GH and a fall in IGF-1 levels in humans, reflecting a GH resistant state (12). In rodents resistance to GH also develops, though both the serum GH and IGF-1 levels usually fall (20) . In addition to this acquired deficiency of IGF-1, tissue resistance to this hormone develops (9) and together with the increase in inflammatory cytokines and glucocorticoids leads to a state of accelerated catabolism (6, 11 ).
The initiating event in GH signaling is binding of hormone to receptor and this activates janus kinase 2 (JAK2), a protein-tyrosine kinase that in turn phosphorylates the receptor on tyrosine residues (22, 36). These events activate several signaling pathways including the signal transducer and activator of transcription (STAT) pathway. Activation requires tyrosine phosphorylation of STAT 1a, 3, 5a and 5b, members of a family of intracellular proteins that serve both as signaling and transcription factors. The phospho-STATs form dimers that enter the nucleus where they bind to specific DNA sequences and activate or repress target genes.
Of the STAT proteins, STAT5b plays an essential role in GH mediated transcription of IGF-1
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subjected to PCR analysis. Results were quantified using the relative standard curve method as described by the supplier. An internal control gene standard curve was also generated and the target gene was normalized for this endogenous control. Each sample was analyzed in triplicate in individual assays performed on two or more occasions.
Western Immunoblotting and Immunoprecipitation. The antibodies that detect STAT5a
(SC-1081 ), STAT5b (SC-1656), both STAT5a and STAT5b (SC-835 ) and protein A and G agarose were from Santa Cruz Biotechnology (Santa Cruz , CA). Phospho-STAT5a/b (05495), JAK2 (06255) and phosphotyrosine-specific (clone 4G10) antibodies were from Upstate Biotechnology (Lake Placid, NY). The GH receptor antibody, directed against the receptor extracellular domain, was a gift from W.R. Baumbach. Liver lysates and nuclear extracts were prepared from frozen liver and used directly for Western immunoblot analysis or subjected to immunoprecipitation before analysis as described previously (25, 29). Tissue lysates (for direct assay of proteins) or immunoprecipitates were heated in Laemmli buffer, separated by electrophoresis on a 7.5% SDS polyacrylamide gel and electroblotted onto nitrocellulose membrane and then immuno-detected with appropriate antibodies and visualized by enhanced Page 6 of 27 chemiluminescence. Protein expression was quantified with a Fluo-S digital image analyzer and Multianalyst software (Bio-Rad, Hercules, CA). Relative density units refer to mean pixel density after local background subtraction.
Electrophoretic Mobility Shift Assay (EMSA). EMSA was performed as described by Ram et al (23) with minor modifications as we described before (26). Nuclear extracts were prepared from 100-mg frozen tissues aliquots using the NE-PER nuclear and cytoplasmic extraction reagents (Pierce Biotechnology Inc, Rockford, IL). Eight micrograms of nuclear protein dissolved in buffer (10mM HEPES [pH 7.5],50 mM NaCl,0.5mM PMSF,0.1 mM EDTA, 1mM dithiothreitol, 0.5mM sodium fluoride,1 mM sodium orthovanadate,1ug/ml pepstain A, and 10% glycerol) was incubated for 10 mins at room temperature with 9 ul of of gel mobility shift buffer(10mM tris-HCL[pH7.5],2 ug of poly(dI-dC),4% glycerol,1mM MgCl 2 , 0.5mM EDTA,0.5mM dithiothreitol, and 50mM NaCl ). Anti-STAT5b monoclonal antibody was then added and incubated for a further 45 mins. Then, the double -stranded oligonucleotide probe, 32 P-labeled on one strand using T4 polynucleotide kinase, was added and incubated for 30 mins. Samples were electrophoresed through non-denaturing polyacrylamide gels (4% acrylamide,0.05% bisacrylamide). The DNA probe used for the mobility shift analysis was a rat -casein probe (STAT5/mammary gland factor response element, nucleotides -101 to -80), 5' GGA CTT GGA ATT AAG GGA-3'(sense strand oligonucleotide, ON-257) and 5'-GTC CCT TAA TTC CAA GAA GTCC-3' (antisense strand, ON-258).
Data analysis and statistics. Tyrosine-phosphorylated protein levels were normalized for the respective protein levels. Specific mRNAs were normalized for the internal control gene and are expressed as transcript/housekeeping gene ratios. The control vehicle treated group mean was given a value of 100, and individual values are expressed relative to this value. Results are given as mean ± SEM. Two-tailed unpaired Student's t-tests were used for comparison of two normally distributed groups. Comparisons between more than two normally distributed groups were made by one-way ANOVA followed by pair-wise multiple comparison with the Holms t test (7) . A p value <0.05 was considered significant.
RESULTS

IGF-1, Cytokine and Suppressor of Cytokine
Signaling mRNA Levels are altered in endotoxemia. In LPS treated rats basal IGF-1 mRNA levels, measured in V treated rats, were reduced significantly to 58% of the V treated control value (figure 1). GH administered to controls induced a significant 65% increase in IGF-1 mRNA expression; in the LPS treated rats the response to GH was sub-optimal and the IGF-1 mRNA levels were significantly lower than in the GH treated controls, reflecting GH resistance. Table 2 summarizes the cytokine and SOCS responses to LPS and GH. LPS alone increased TNF mRNA levels 292 fold (p< 0.001), while GH alone did not alter the levels. However when GH was administered to LPS treated rats, the TNF mRNA levels increased even further to 605 fold the basal value (p< 0.001). LPS alone produced a remarkable increase in IL-6 expression to 423 fold the basal control value (p< 0.001). When GH was added to LPS, IL-6 expression increased to 567 fold the basal control value, a value that did not differ statistically from LPS alone.
LPS and GH each caused a significant increase in SOCS mRNA expression when given alone, though the pattern of response differed somewhat (table 2) . LPS increased SOCS1, SOCS3 and CIS mRNA levels by 16, 10 and 6 fold respectively (p< 0.001), but did not effect SOCS2 expression significantly. GH alone increased SOCS2, SOCS3 and CIS mRNA levels 9, 2 and 4 fold respectively (p<0.001), but did alter SOCS1 expression. When GH was given to LPS treated animals there was a marked further increase in SOCS1 mRNA to 58 fold basal level and a modest increase in CIS mRNA levels (p< 0.001) but there was no further increase in SOC3 levels. Interestingly the SOCS2 response to GH which is also dependent on STAT5b (39), was significantly depressed in the LPS group. When GH was given to control animals the SOCS2 mRNA levels increased 9 fold, but when given to LPS treated rats it increased only 3 fold (p>0.001). Taken together, the cytokine and SOCS responses to LPS observed are consistent with earlier studies that have implicated these proteins as a cause of endotoxin mediated GH resistance (3, 11, 16) . The impact of GH on TNF , SOCS 1, SOCS2 and CIS mRNA levels in the LPS treated rats is of special note, as it is conceivable that this response to GH may contribute to the reported adverse effects of GH when administered to endotoxic rats (13, 14) and to critically ill patients (30, 33).
GH-Mediated JAK2/STAT5 Signal Transduction is impaired in endotoxemia.
In liver the GHR, JAK2 and STAT5a/b protein levels were similar in the LPS and control groups (Fig 2A) .
In animals not given GH, basal tyrosine phosphorylation of STAT5a/b measured in whole liver lysates (Fig 2B) , was significantly reduced in the LPS group compared to the controls (averaging 25 ± 4.5% of the control values, p<0.001). Fifteen minutes after a bolus of bGH, 100 µg/kg body wt, tyrosine phosphorylation of JAK2 and STAT5/ab was markedly increased in the control group ( Figure 2C ). In the LPS treated rats GH stimulated tyrosine phosphorylation of 
DISCUSSION.
Administration of endotoxin induces a marked systemic response with the release of cytokines, catecholamines and glucocorticoids, blood pressure falls and there are profound metabolic alterations (34, 35). In addition to these systemic perturbations that contribute to the development of growth hormone resistance, it is established that LPS also induces growth hormone resistance by a direct cellular action. This is initiated by the binding of LPS to Toll-like receptors in hepatocytes and muscle cells that mediate the release of pro-inflammatory cytokines and nitrous oxide that in turn induce a growth hormone resistant state (6, 21, 24) . In this study we set out to explore the cellular mechanisms whereby endotoxin induces resistance to GH in liver as this organ is the main source of circulating IGF-1, the levels of which fall when endotoxemia is present (4, 12, 20) . Bacterial LPS or saline was administered to normal rats and they were studied four hours later. Some rats were treated with GH over this period to stimulate IGF-1 gene expression, while others received a single bolus of GH to stimulate the JAK2- including GH, which stimulates SOCS-1, -2, -3 and CIS expression (31, 40). In endotoxin treated rats we found that hepatic mRNA levels of TNF and IL-6 increased 300-400 fold and this was associated with an increase in SOCS1, SOCS3 and CIS mRNA levels. Of particular interest was the response to GH in endotoxin treated rats. While GH did not alter TNF or IL-6 expression in the control animals, in the endotoxic rats GH caused a further increase in TNF and to a lesser extent, IL-6 expression; on average the mRNA levels rose ~600 fold the basal control values. SOCS 1 expression also increased further. In contrast the SOCS2 response to GH which is dependent on STAT5b (39), was significantly depressed in endotoxemia. When GH was given to control animals the SOCS2 mRNA levels increased 9 fold, but when given to endotoxic rats it increased only 3 fold. Taken together it is conceivable that these alterations in the hepatic response to GH may contribute to the GH induced hypersensitivity to endotoxin induced injury described in rats (13, 14), and to the increase in morbidity and mortality induced by high dose GH therapy in critically ill patients (30, 33).
It is well established that inflammation leads to a fall in circulating and local IGF-1 levels. In the DNA binding activity was also reduced. As the data was not quantified, it is unclear whether or not the decrease in binding activity was proportional to the fall in phospho-STAT5 levels.
Apart from the contribution of impaired GH stimulated JAK2-STAT5b phophorylation and nuclear translocation to the reduced STAT5b DNA binding activity that we observed in the endotoxic rats, the mechanisms accounting for the disproportional decrease in GH stimulated 
